# Page 1
In the financial year 2020-21, revised administrative approval has been accorded for procurement of drugs, pharmaceuticals and related items from Haffkine Jeeva Aushadhi Mahamandal as per self-produced and fixed prices from the funds sanctioned under various heads under National Health Mission/ State Grants.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: PRASHAMA-1222/ PR No.14/ HEALTH-7
10th Floor, Hospital Building
New Ministry, Mumbai- 400001.
Date: August 2, 2022
(1) Government Resolution, Department of Public Health, No.PRASHAMA-1220/ Q.No.31/ HEALTH-7, dated 20th October, 2020.
(2) Government Resolution, Department of Public Health, No: PRASHAMA-1220/ PR No.31/ HEALTH-7, dated: 05th May, 2021.
(3) Government Decision, Department of Public Health, No: PRASHAMA-1221/ PR No. 36/ Health-7, dated: 28th December, 2021.
(4) General Manager, Haffkine Biopharmaceuticals Limited, Parel, Mumbai-12 vide letter No. 4684-87/ Haffkine/ Purchase Cell/ Cargo List/ 2020-21, dated: 28.04.2022.
(5) Letter from Joint Director (Procurement Cell), Commissionerate of Health Services, Mumbai No: By/ Procurement Cell, Mumbai/ regarding receipt of revised administrative approval in respect of direct revision of Haffkine Corporation self-generated items proposed in the year 2020-21/ 1632-33/2022, dated: 27th May, 2022.
(6) Note approved by the Commissioner Health Services and Mission Director and Mission Director, National Health Mission, Mumbai dated 26.05.2022.
(7) Letter from the Joint Director (Procurement Cell), Commissionerate of Health Services, Mumbai No: By/ Procurement Cell, Mumbai/ Regarding Revised Administrative Approval for Direct Procurement of Haffkine Corporation Self-Produced Items Proposed in 2020-21/ 3781 82/ 2022, dated: 28th July, 2022.
# Page 2
Government Resolution No: PRASHAMA-1222/ PR No.14/ HEALTH-7
(8) Government Resolution, Department of Public Health, No: Purchase-2016/ PR No. 240/ Health-8, dated: 26th July, 2017.
The Proposal:
In pursuance of the decision of the Government under reference number (1), an amount of Rs. 527.25 crore was accorded as administrative sanction for procurement of various types of drugs, pharmaceuticals and allied items from the funds available under various heads of accounts under the National Health Mission (NHM) and from the grants available under various heads of State Grants-in-Aid during the financial year 2020-21. As the case may be, vide Government Resolution No. (2) under reference, administrative approval was accorded for procurement of drugs and pharmaceutical materials under the component of Free Drug Services under the Supplementary Project Implementation Plan (PIP) for the year 2020-21 under the National Health Mission (NHM) for an amount of Rs. 28.04 crore under the head" 6.2.21.1." Further, as per the decision of the Government vide Reference No. (3), an amount of Rs. 302.04 crore was accorded as administrative approval for procurement of drugs, pharmaceutical ingredients and other allied items from the funds sanctioned under the heading" FMR Code" in the Project Implementation Plan (PIP) during the financial year 2021-22.
During the financial year 2020-21, administrative approval was accorded at the Government level for procurement of drugs, pharmaceuticals and related items under various heads under National Health Mission and State Grants, as per the rates submitted by the Health Service Commissionerates. However, the rates as per administrative approval for subject purchase
Since it is estimated that the Haffkine Biopharmaceuticals Corporation (M.I.T. ), Mumbai, informed the Commissionerate of Health Services to procure the matter self-produced by the Corporation as per the price list fixed under letter of reference No. (4), as well as the approval taken by the Tender Approval Committee. Accordingly, Haffkine Jeeva Pharmaceuticals Limited has fixed the rates for the purchase of medicines and pharmaceuticals as per the provisions of the Government Order, Industries, Power and Labour Department, No: Bhankhas 2014/ PR No.82/ Part-III/ Industry-4, dated 01.12.2016 on a total of 04 items to be procured by the Commissionerate of Health Services as follows:
HAFFKINE BIO PHARMACEUTICAL CORPORATION LIMITED
-------------------------------------------------------------------------------------------
| Sr.No. | Name of Item                                           | HBPCL Price (In Rs. ) |
| 1      | ASVS (Lyophilysed prolyvalent Anti snake venmom serum) | 560.00                |
| 2      | Tab Metformin 500m                                     | 1.6576                |
| 3      | Amoxycillin 250mg                                      | 2.74168               |
| 4      | Amoxycillin 500mg                                      | 4.7104                |
-------------------------------------------------------------------------------------------
Page 2 of 6
# Page 3
Government Resolution No: PRASHAMA-1222/ PR No.14/ HEALTH-7
The Commissionerate of Health Services vide letter no. (5) under reference, as per the new rates of self-produced Total-04 items of Haffkine Jeeva Pharmaceuticals Corporation as shown in the said table
Improvement in direct procurement of medicines, pharmaceuticals and related items by reducing the number of cases.
The government has sought administrative sanction for the same. Also, the subject matter of the purchase proposal
Commissioner Health Services and Mission Director, National Health Mission, Mumbai
(6) has been approved.
Meanwhile, for the purposes of the subject matter, the Commissionerate of Health Services vide letter No. 7
Self-produced by Haffkine Jeeva Pharmaceutical Corporation by reducing the number of cases as per the new rates
the cap. Amoxicillin 250mg, cap. Amoxicillin 500mg, Tab Metformin 500m and Anti-Snake
Venon Serum 10 ml Vial- a total of 04 such medicines, pharmaceuticals and related matters
Rs. 27,98,17, 832/- (Rupees Twenty Seven Crore Ninety Eight Lakh Seventeen Thousand) for Direct Purchase
Eight hundred and thirty two only) has been requested for grant of revised administrative approval.
Accordingly, the matter of giving revised administrative sanction to the said amount was under consideration of the Government.
Government's decision:
National Health Mission and State Grants for 2020-21
Subsidies available under the head Medicines, Medicinal Materials and allied items.
The procurement cell of Haffkine Biopharma Corporation for the purchase of the original administrative
It was reported that a rate of 10% more than the approved amount was received. Accordingly, at the request of the Commissioner of Health Services, the actual number of drugs under various heads of accounts under the National Health Mission has been reduced to 10% or more of the administrative approval.
Subject-wise revised for direct purchase of Medicinal Ingredients and allied items as under:
Administrative approval has been granted:
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Sr. No.                  | Budget Source / Year of Proposal/ A.A.GR.Date | Scheme    | Quantity | Rate as per A.A. | A.A. Amount | Revised Rate @ HBPCL | Amount Required as per New Rate | Difference in Amount | Revised Consignee Quantity w.r.t. A.A. Amount | Final Revised Amount Purchase ( In Rs. ) |
| 1                        | 2                                             | 3         | 4        | 5                | 6           | 7                    | 8                               | 9                    | 10                                            | 11                                       |
| Cap. Amoxycilline 250mg  |
| 1                        | NHM Budget 2020-21 (GR. Date : 20.10.2020.)   | Free Drug | 15000000 | 0.9485           | 14227500    | 2.74168              | 41125200                        | -26897700            | 5189000                                       | 14226548                                 |
| HWC                      | 25000000                                      | 0.9485    | 23712500 | 2.74168          | 68542000    | -44829500            | 8648000                         | 23710049             |
| RBSK                     | 20689340                                      | 0.9485    | 19623839 | 2.74168          | 56723550    | -37099711            | 7157000                         | 19622204             |
| JSSK                     |
| Cap. Amoxycilline 500 mg |
| 2                        | NHM Budget 2020-21 (GR. Date : 20.10.2020.)   | Free Drug | 3000000  |                  | 51279000    | 104                  | 000                             | -90033000            | 10 30000                                      | 51249152                                 |
| HWC                      | 26000000                                      | 1.7093    | 44441800 | 4.7104           | 122470400   | -78028600            | 9430000                         | 44419072             |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Page 3 of 6
# Page 4
Government Resolution No: PRASHAMA-1222/ PR No.14/ HEALTH-7
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Sr. No.                                                        | Budget Source / Year of Proposal/ A.A.GR.Date | Scheme | Quantity | Rate as per A.A. | A.A. Amount | Revised Rate @ HBPCL | Amount Required as per New Rate | Difference in Amount | Revised Consignee Quantity w.r.t. A.A. Amount | Final Revised Amount of Purchase ( In Rs.) |
| 1                                                              | 2                                             | 3      | 4        | 5                | 6           | 7                    | 8                               |                      | 10                                            | 11                                         |
| Tab. Metformin 500mg                                           |
| 3                                                              | NHM Budget 2020-21 (GR. Date : 20.10.2020.)   | NPCDCS | 50000000 | 0.25             | 12500000    | 1.6576               | 82880000                        | -70380000            | 7540000                                       | 12498304                                   |
| HWC                                                            | 45000000                                      | 0.25   | 11250000 | 1.6576           | 74592000    | -63342000            | 6786000                         | 11248474             |
| Anti-Snake Venom Serum 10 ml Vial                              |
| NHM Budget 2021-22 ( GR. Date : 28.12.2021.)                   | Free Drug                                     | 200000 | 514.25   | 102850000        | 560         | 112000000            | -9150000                        | 183650               | 102844000                                     |
| Total amount of Proposed for REVISED ADMINISTRATIVE APPROVAL.. | 279817832                                     |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Commissionerate of Health Services produces Haffkine Jeeva medicine as shown in the above table
A total of-04 items of drugs, pharmaceuticals, and related products self-produced by the Corporation
Direct Benefit of Rs. 27,98,17, 832/- (Rupees Twenty Seven Crores Ninety Eight Lakh Seventeen Lakhs Seventy Two)
One thousand eight hundred and thirty-two only), subject to the following terms and conditions, the revised administrative
It is approved:
Terms and Conditions:
(1) The medicines, medical equipment, machinery and consumables and other necessary
Requirement/ demand of the material should be ascertained. After that
The procurement process should be followed.
(2) Medicines, medical devices, consumables and other necessary materials.
It should be verified. Technical specifications of the items to be purchased
Specification) approved by the concerned experts (Technical Committee/ Officials).
It should be according to the guidelines.
(3) Government Decision, Department of Industry, Energy and Labour, No. 2014/ No. 82/ Part-II/
Industries- 4 Government Departments notified as on 01.12.2016
Revised Manual of Procedure for Office Purchases to be made
The procurement process should be carried out as per the provisions.
(4) Proposed drugs from the self-produced matter of Haffkine Biopharmaceutical Corporation and
Medicines will be purchased. Also, Haffkine Biopharmaceuticals
Government Resolution, Industries, Power and Labour Department, No. Bhankhas-2014/ P. No.82/ Part
III/ Industry-4, dated 31.03.2022 as per the provisions of 01.12.2016
will be purchased at the rate.
Page 4 of 6
# Page 5
Government Resolution No: PRASHAMA-1222/ PR No.14/ HEALTH-7
(5) Pre/ post dispatch random sample inspection of the items to be purchased should be done to ensure that only those items with proper and correct specifications are purchased.
(6) It shall be ensured that after the supply of the items to be purchased, the items do not remain unused and are used within the stipulated time.
(7) Expenditure on drugs, pharmaceuticals and related items The grants sanctioned under the head" 21 Supplies and Supplies" for the financial year 2020-21 under the head" 2210 0226, 2210 4259, 2210 G298, 2210 0146, 2210 04413, 2210 E482, 2210 0941, 2210 0665, 2210 5175, 22100674, 22100291, 22100191" will be shared and disbursed by the Finance Department. Also, the Commissioner and Mission Director and the concerned Programme Head will be fully responsible for the actual procurement within the limit of subsidy disbursed.
(8) It should be ensured that there is no duplication of the purchase.
(9) The guidelines of the Central Vigilance Commission (CVC) should be strictly followed while carrying out the entire procurement process.
The conditions set out in Annexure to Regulation No. 30/2013/ Regulations, Part-II, dated 17.04.2015, to the Financial Powers Rules, 1978, Part-I, Sub-Division-II, No. 4, Rule No. 7 in front of Column No. 6 should be complied with.
(11) The supply order shall be issued only after the approval of the Procurement Committee after the process of the proposed procurement is completed. Further, action should be taken in accordance with the provisions of the Government Resolution, Public Health Department, No: Purchase-2016/ PR No. 240/ Health-8, dated 26th July, 2017.
(12) On completion of the process of the proposed procurement, supply orders shall be issued only after approval of the Procurement Committee. Further, action in the matter should be taken in accordance with the provisions of the Government Resolution, Department of Public Health, No: Purchase-2016/ PR No. 240/ Health-8, dated 26th July, 2017.
The Commissioner, Director of Health Services and Mission, National Health Mission, Director, Directorate of Health Services and Head of the Programme shall be solely responsible for ensuring that the conditions mentioned in the above Annexure (1) to (12) are met and the procurement is as per the rules and requirements.
Page 6 of 5
# Page 6
Government Resolution No: PRASHAMA-1222/ PR No.14/ HEALTH-7
The Administrative Department has been granted full powers to approve the purchase of implements, retail equipment and activity kits under Article 4, Rule 7 of the Financial Powers Rules Book 1978 Part-I Sub-Division-II of the Government Decision, Finance Division, No.Viapr-2013/ Q.S. 30/13/ Regulations, Part-II, dated 17th April, 2015. Accordingly, the government has taken the decision.